A
Vanda Pharmaceuticals Inc 9605 Medical Center Drive # 300 Category: Drugs Acting On the Central Nervous System & Sense Organs |
Company representatives
Becca Lannan, Chief Marketing Officer
Argeris Karabelas, Chairman
Mihael H Polymeropoulos, President & Chief Executive Officer
Location Type
Headquarters
Revenue
$35,000,000 - $37,500,000
Employees
20
Years In Business
21
Stock symbol
VNDA
State of incorporation
Maryland
SIC code
283407 (Laboratories-Pharmaceutical (Mfrs))
NAICS code
325412 (Pharmaceutical Preparation Manufacturing)
Rating
Browse U.S. states for Drugs Acting On the Central Nervous System & Sense Organs
